Your institution may have access to this item. Find your institution then sign in to continue.
Title
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
Authors
Alatrash, Gheath; Albitar, Maher; O'Brien, Susan; Wang, Xuemei; Manshouri, Taghi; Faderl, Stefan; Ferrajoli, Alessandra; Burger, Jan; Garcia-Manero, Guillermo; Kantarjian, Hagop M.; Lerner, Susan; Keating, Michael J.; Wierda, William G.
Publication
British Journal of Haematology, 2010, Vol 148, Issue 3, p386